Sunflower Pharmaceutical Group Co.,Ltd
002737.SZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.92B
Close$
$23.14
91.7% upside
Current Fair Value
91.7% upsideUndervalued by 91.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.92 Billion |
|---|---|
| Enterprise Value | $5.96 Billion |
| Annual dividend | $0.20 |
| Dividend yield | 1.69% |
| Earnings per Share | $-0.44 |
| Beta | 0.26 |
| Outstanding Shares | 0 |
Return
| Return on Equity | -3.59% |
|---|---|
| Return on Assets | -2.65% |
| Return on Invested Capital | -1.88% |
Valuation & Multiples
| P/E Ratio | -58.43 |
|---|---|
| PEG | 56.43 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | -73.85 |
| Enterprise Value to Net Income | -43 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 22, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sunflower Pharmaceutical Group Co.,Ltd
5,025 employees
CEO: Yi Guan
Sunflower Pharmaceutical Group Co., Ltd. is a Chinese enterprise dedicated to the comprehensive process of traditional Chinese medicine (TCM), covering everything from research and development to production and market distribution within...